Welcome

Welcome to EUSA Pharma

EUSA Pharma is a specialty pharmaceutical company with a strong and growing portfolio of specialized hospital medicines focused on oncology, pain control and critical care, which it markets predominantly in Europe and the US (as the company’s name suggests).

EUSAPharma has grown rapidly since its formation in 2006, and now incorporates the acquisition of Talisker Pharmaceuticals, which it acquired in July 2006, OPi, which it purchased in March 2007 and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc, which EUSA acquired in August 2007.